Education
About Us
Working with TipRanks
Follow Us
Rainer Erdtmann Insider Profile
11 Followers
Rainer Erdtmann, Sr. VP, IR and Admin at Pharmacyclics, holds 2.57M shares in Biomea Fusion (Ticker: BMEA), holds 50.00K shares in PolarityTE (Ticker: RGTPQ), holds 5.70K shares in Pharmacyclics (Ticker: PCYC). Most recently, Rainer Erdtmann Bought ― shares of Biomea Fusion on Dec 15, 2025 for an estimated value of $42.90K.
Rainer Erdtmann Pharmacyclics (PCYC)Sr. VP, IR and Admin
Pharmacyclics (PCYC)
Sr. VP, IR and Admin
Ranked #26,227 out of 105,219 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+10.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rainer Erdtmann holds in companies
Most Profitable Insider Trade
Stock:
PolarityTE
(RGTPQ)
(RGTPQ)
Rating:Informative Sell
Date:Dec 17, 2019 - Dec 17, 2020
Return:+75.40%
The most profitable trade made by Rainer Erdtmann
Rainer Erdtmann's Trading History
Pharmacyclics
May 01, 2014
―
Uninformative Buy
16.40K
―
PolarityTE
Dec 17, 2019
―
Informative Sell
78.66K
$7.80K
Summit Therapeutics
―
Director
―
―
Biomea Fusion
Dec 15, 2025
President, COO, Principal Financial Officer, and Principal Accounting Officer, Director
Informative Buy
42.90K
$3.47M
List of latest transactions for each holding click on a transaction to see Rainer Erdtmann's performance on stock
You May Also Like
Rainer Erdtmann insider profile FAQ
What is the percentage of profitable transactions made by Rainer Erdtmann?
The percentage of profitable transactions made by Rainer Erdtmann is 80%.
What is the average return per transaction made by Rainer Erdtmann?
The average return per transaction made by Rainer Erdtmann is 10.30%.
What stocks does Rainer Erdtmann hold?
Rainer Erdtmann holds: PCYC, RGTPQ, SMMT, BMEA stocks.
What was Rainer Erdtmann’s latest transaction?
Rainer Erdtmann latest transaction was an Informative Buy of $42.90K.
What was Rainer Erdtmann's most profitable transaction?
Rainer Erdtmann’s most profitable transaction was an Informative Sell of RGTPQ stock on December 17, 2019. The return on the trade was 75.40%.
What is Rainer Erdtmann's role in Pharmacyclics?
Rainer Erdtmann's role in Pharmacyclics is Sr. VP, IR and Admin.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.